Glenmark Pharmaceuticals USA lobbies on its own behalf. For Q2 2024 it reported $0 across 1 client report and lists 1 lobbyist across its filings.
| Client | Reported | Issues |
|---|---|---|
| GLENMARK PHARMACEUTICALS USA | $0 |
| Year | Reported | Clients |
|---|---|---|
| 2024 | $0 | 1 |
| 2023 | $0 | 1 |
| 2022 | $601K | 1 |
| 2021 | $897K | 1 |
| 2020 | $897K | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.